Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

This publication has 44 references indexed in Scilit:

• Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways
  Oncogene, 1999
• τ is phosphorylated by GSK‐3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A‐kinase
  FEBS Letters, 1998
• WNT-1 and HGF Regulate GSK3β Activity and β-Catenin Signaling in Mammary Epithelial Cells
  Biochemical and Biophysical Research Communications, 1998
• Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β
  Published by Elsevier ,1998
• Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase‐3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin
  FEBS Letters, 1998
• Insulin-Stimulated Glycogen Synthesis in Cultured Hepatoma Cells: Differential Effects of Inhibitors of Insulin Signaling Molecules
  Journal of Receptors and Signal Transduction, 1998
• Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
  FEBS Letters, 1997
• Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells
  Current Biology, 1996
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
  Nature, 1995
• Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells
  Neuroscience Letters, 1995